Welcome to our dedicated page for Purple Innovatio SEC filings (Ticker: PRPL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Purple Innovation’s GelFlex® Grid may feel simple on your mattress, but the disclosures behind that comfort span hundreds of SEC pages. If you have ever searched for "Purple Innovation SEC filings explained simply" or puzzled over marketing spend buried in a 10-K, you know the challenge.
Stock Titan turns those dense documents into clarity. Our AI delivers real-time "Purple Innovation Form 4 insider transactions" alerts, surfaces warranty return trends hidden in the latest "Purple Innovation quarterly earnings report 10-Q filing", and offers one-click access to every "Purple Innovation 8-K material events explained" note. Whether you need "understanding Purple Innovation SEC documents with AI" or a concise "Purple Innovation annual report 10-K simplified" summary, the platform answers in seconds.
Use the page to:
- Track "Purple Innovation executive stock transactions Form 4" the moment they hit EDGAR.
- Compare gross-margin shifts with our "Purple Innovation earnings report filing analysis".
- Preview board pay details via the "Purple Innovation proxy statement executive compensation" section.
No more digging for "Purple Innovation insider trading Form 4 transactions" or waiting days for updates—our AI-powered summaries, keyword search, and historical charting make complex filings approachable and actionable.
Purple Innovation (PRPL) reported a Nasdaq compliance notice. The company fell out of compliance with Nasdaq Listing Rule 5450(a)(1) after its Class A common stock’s closing bid stayed below $1.00 per share for 30 consecutive business days. The notice has no immediate effect on trading on the Nasdaq Global Select Market.
Purple has 180 calendar days, until May 4, 2026, to regain compliance by achieving a closing bid of at least $1.00 for ten consecutive business days. If it does not regain compliance by then, the company may seek an additional 180-day period by transferring to the Nasdaq Capital Market, subject to meeting that market’s initial standards (other than bid price) and notifying Nasdaq it intends to cure the deficiency, which may include a reverse stock split. If compliance is not restored or a transfer is not permitted, Nasdaq could move to delist, and the company could appeal.
Purple Innovation, Inc. furnished an 8‑K to announce it issued a press release with financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The company stated the information under Item 2.02, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act. The release includes non‑GAAP financial measures, with reconciliations to the most comparable GAAP figures provided in the press release.
Purple Innovation, Inc. (PRPL) filed its Q3 2025 10‑Q, showing steady revenue and a smaller operating loss versus last year. Revenue was $118,766, with gross profit of $50,851 and an operating loss of $12,126 compared with a $46,813 loss a year ago. Net loss was $11,720 (basic and diluted loss per share $0.11).
Channel mix reflected a balanced model: wholesale $51,541, e‑commerce $45,275, and showrooms $21,950. Cash and cash equivalents were $32,358 as of September 30, 2025, and the company reported a stockholders’ deficit of $(26,939). Related party debt (net of issuance costs) was $102,889, with interest largely paid‑in‑kind year‑to‑date.
The company continued executing its 2024 restructuring, cumulatively recognizing $48,779 in restructuring, impairment, and related charges through Q3 2025, while noting cost actions and supply chain initiatives. A commercial update with Mattress Firm (SGI) expands product placement from ~5,000 to at least 12,000 mattress slots. Management concluded it has sufficient liquidity for at least one year from issuance.
SomniGroup International Inc. filed a Schedule 13G reporting beneficial ownership of 8,000,000 shares of Purple Innovation, Inc. Class A common stock, representing 6.88% of the class. The filing states these 8,000,000 shares "could be acquired" upon exercise of warrants at an exercise price of $1.50 per share, subject to adjustment. The percent calculation is based on 108,243,946 Class A shares outstanding as reported by the issuer on July 28, 2025. SomniGroup reports sole voting and dispositive power over the 8,000,000 shares and certifies the holdings were not acquired to influence control.
On August 7, 2025, Purple Innovation, Inc. amended two executive compensation arrangements. The company executed an amendment to Robert T. DeMartini’s Amended and Restated Employment Agreement to revise the definition of a change in control. On the same date the Board approved an amendment to the form Restricted Share Unit (RSU) Agreement for selected senior leaders that provides 100% vesting of each participant’s RSUs if the company terminates the participant’s employment without cause and likewise revises the change-in-control definition.
The filings incorporate the full amendment texts as Exhibits 10.1 and 10.2 and include the Inline XBRL cover page as Exhibit 104. Named officers referenced include Todd Vogensen, John J. Roddy, and Eric S. Haynor. The summaries reported here are qualified in their entirety by the filed exhibits.
FAQ
What is the current stock price of Purple Innovatio (PRPL)?
What is the market cap of Purple Innovatio (PRPL)?
